In the present work, we find that micropeptide hSPAR acts as an intrinsic regulator of glutamine metabolism by repressing the glutamine transporter SLC38A2 and demonstrate that glutamine deprivation is the key to mediating the anti-tumor effect of hSPAR. This evidence concerns the gene SLC38A2 and neoplasm.